1. Mineral bone disorders and kidney disease in hospitalized children with sickle cell anemia
- Author
-
Anthony Batte, Philip Kasirye, Reagan Baluku, Sarah Kiguli, Robert Kalyesubula, Chandy C. John, Andrew L. Schwaderer, Erik A. Imel, and Andrea L. Conroy
- Subjects
mineral bone disease ,acute kidney injury ,sickle cell anemia (SCA) ,mortality ,pediatrics ,acute kidney disease (AKD) ,Pediatrics ,RJ1-570 - Abstract
BackgroundMineral bone disorders (MBD) are common in sickle cell anemia (SCA). Frequent vaso-occlusive crises (VOC) further impact MBD in children with SCA. We evaluated the prevalence of markers of SCA-related MBD (sMBD) in hospitalized children and assessed the relationship between sMBD and individual mineral abnormalities with kidney disease.MethodsWe prospectively recruited 185 children with SCA hospitalized with a VOC. Serum measures of mineral bone metabolism (calcium, phosphate, parathyroid hormone, 25-hydroxy vitamin D, FGF23, osteopontin) were measured at enrollment. The primary outcome was markers of sMBD defined as a composite of hypocalcemia, hyperphosphatemia, hyperparathyroidism, or deficiency in 25-OH vitamin D. Secondary outcomes included individual abnormalities in mineral metabolism. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines were used to define SCA-associated acute kidney injury (AKI). AKI was further assessed using urine NGAL as a marker of tubular injury. Acute kidney disease (AKD) was defined as a composite of AKI, an eGFR
- Published
- 2023
- Full Text
- View/download PDF